Literature DB >> 19782431

De-escalation for amoxicillin-susceptible Escherichia coli: easier said than done.

A D Donaldson, T Barkham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19782431     DOI： 10.1016/j.jhin.2009.07.013

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  7 in total

1.  De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients.

Authors:  N Shime; S Satake; N Fujita
Journal:  Infection       Date:  2011-04-21       Impact factor: 3.553

Review 2.  De-escalating Antibiotic Use in the Inpatient Setting: Strategies, Controversies, and Challenges.

Authors:  J Daniel Markley; Shaina Bernard; Gonzalo Bearman; Michael P Stevens
Journal:  Curr Infect Dis Rep       Date:  2017-04       Impact factor: 3.725

3.  Antibiotic de-escalation in bacteremic urinary tract infections: potential opportunities and effect on outcome.

Authors:  F A Khasawneh; A Karim; T Mahmood; S Ahmed; S F Jaffri; M E Tate; M Mehmood
Journal:  Infection       Date:  2014-05-30       Impact factor: 3.553

4.  Why is antimicrobial de-escalation under-prescribed for urinary tract infections?

Authors:  E Duchêne; E Montassier; D Boutoille; J Caillon; G Potel; E Batard
Journal:  Infection       Date:  2012-11-04       Impact factor: 3.553

5.  Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia.

Authors:  Faisal A Khasawneh; Adnanul Karim; Tashfeen Mahmood; Subhan Ahmed; Sayyed F Jaffri; Mansoor Mehmood
Journal:  Infect Drug Resist       Date:  2014-06-27       Impact factor: 4.003

6.  Audit of Antibiotic Practices: An Experience from a Tertiary Referral Center.

Authors:  Ritu Singh; Afzal Azim; Mohan Gurjar; Banani Poddar; Arvind K Baronia
Journal:  Indian J Crit Care Med       Date:  2019-01

7.  De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: an observational study.

Authors:  Rafael Barberena Moraes; Julián Alberto Viteri Guillén; William Javier Castillo Zabaleta; Flavia Kessler Borges
Journal:  Rev Bras Ter Intensiva       Date:  2016-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.